Grapevine, TX, United States of America

Robert M Kral, Jr

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 354(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Innovations and Contributions of Robert M Kral, Jr.

Introduction

Robert M Kral, Jr. is a notable inventor based in Grapevine, TX (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, Kral has made strides in developing novel compounds and methods that address various health issues.

Latest Patents

Among his latest patents, Kral has developed natural product analogs that include an anti-inflammatory cyanoenone pharmacore. This invention provides novel compounds that comprise an anti-inflammatory pharmacore, along with pharmaceutical compositions, kits, and articles of manufacture that utilize these compounds. Additionally, he has worked on synthetic triterpenoids and methods for their use in treating diseases such as renal/kidney disease, insulin resistance/diabetes, fatty liver disease, and cardiovascular disease.

Career Highlights

Kral has had a distinguished career, working with reputable organizations such as Reata Pharmaceuticals, Inc. and Dartmouth College. His work has focused on innovative solutions that have the potential to improve patient outcomes in various medical conditions.

Collaborations

Throughout his career, Kral has collaborated with esteemed colleagues, including Michael B Sporn and Karen T Liby. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Robert M Kral, Jr. continues to be a driving force in the field of pharmaceutical innovation, with his patents reflecting a commitment to improving health through scientific advancements. His work exemplifies the impact of dedicated inventors in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…